About Tensive
Tensive is a company based in Milano (Italy) founded in 2012 by Valentina Morigi, Alessandro Tocchio, and Gianfranco Bellezza. Tensive has raised $16.67 million across 7 funding rounds from investors including Mediobanca Private Banking, European Union and EIC Fund. Tensive offers products and services including REGENERA. Tensive operates in a competitive market with competitors including Sientra, Establishment Labs, GC Aesthetics, AirXpanders and BioAesthetics, among others.
- Headquarter Milano, Italy
- Founders Valentina Morigi, Alessandro Tocchio, Gianfranco Bellezza
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tensive S.R.L.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$16.67 M (USD)
in 7 rounds
-
Latest Funding Round
$14.58 M (USD), Series A
Jan 31, 2025
-
Investors
Mediobanca Private Banking
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tensive
Tensive offers a comprehensive portfolio of products and services, including REGENERA.
Biodegradable scaffold for breast reconstruction and tissue regeneration.
People of Tensive
Unlock access to complete
Funding Insights of Tensive
Tensive has successfully raised a total of $16.67M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $14.58 million completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Tensive
Tensive has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Mediobanca Private Banking, European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Venture capital and fund of funds focused on multiple sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Tensive
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tensive
Investment portfolio details for Tensive
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Tensive
Detailed financials for Tensive
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tensive Comparisons
Peer comparison for Tensive
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tensive
Tensive operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sientra, Establishment Labs, GC Aesthetics, AirXpanders and BioAesthetics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Products for plastic surgery and aesthetics are developed and marketed.
|
|
| Locked | Locked | Locked |
Silicone-filled breast and body shaping implants are designed and manufactured.
|
|
| Locked | Locked | Locked |
Silicone breast implants are developed for reconstruction and aesthetic surgery.
|
|
| Locked | Locked | Locked |
Tissue expansion technology for breast reconstruction surgery is developed.
|
|
| Locked | Locked | Locked |
Tissue-engineered nipple-areolar complexes are developed for post-mastectomy use.
|
|
| Locked | Locked | Locked |
Therapeutics for female pelvic disorders, including SUI treatments, were developed.
|
Detailed competitors of Tensive
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tensive
Complete news archive for Tensive
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tensive
Tensive was founded in 2012 and raised its 1st funding round 4 years after it was founded.
Tensive is headquartered in Milano, Italy.
Tensive is a funded company, having raised a total of $16.67M across 7 funding rounds to date.
Tensive was established in 2012 as a spin-off of Fondazione Filarete in Milano, Italy. Biomedical innovations in prostheses for breast reconstruction or augmentation are pursued by the company. Products remain in laboratory testing and have not been evaluated on humans. Synthetic and biodegradable biomaterials are utilized to promote fat tissue regeneration, with the prostheses designed for gradual degradation and replacement by patient tissue.
Tensive's top competitors include Establishment Labs, GC Aesthetics and Sientra.
Tensive offers REGENERA.
Tensive has 5 investors. Key investors include Mediobanca Private Banking, European Union, EIC Fund, CDP Venture Capital, and UniCredit Start Lab.